Previous Close | 10.79 |
Open | 10.79 |
Bid | 10.79 x 1200 |
Ask | 11.00 x 1400 |
Day's Range | 10.79 - 10.82 |
52 Week Range | 10.24 - 11.23 |
Volume | |
Avg. Volume | 8,631 |
Market Cap | 22.4M |
Beta (5Y Monthly) | -0.00 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.17 |
Earnings Date | Aug 18, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 32.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for BRLI
January 24, 2023 | Source: Brilliant Acquisition Corporation New York, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until February 23, 2023. In connection with the extension, Nukkleus, Inc. (“Nukkleus”) has deposited $21,350 in Brilliant’s trust account, representing $0.0525 per public ordinary share of Brilliant curre
December 19, 2022 | Source: Brilliant Acquisition Corporation New York, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until January 23, 2023. In connection with the extension, Nukkleus, Inc. (“Nukkleus”) has deposited $22,600 in Brilliant’s trust account, representing $0.04 per public ordinary share of Brilliant current
November 18, 2022 | Source: Brilliant Acquisition CorporationNew York, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until December 23, 2022. In connection with the extension, Nukkleus, Inc. (“Nukkleus”) has deposited $22,600 in Brilliant’s trust account, representing $0.04 per public ordinary share of Brilliant current